DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Di Giacomo AM, Ascierto PA, Pilla L. et al.
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
Lancet Oncol 2012;
13: 879-886
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.